BUZZ-GSK: Reverses course after Q4 results beat
** GlaxoSmithKline (Other OTC: GLAXF - news) 's shares up 2 pct, 3rd-largest FTSE 100 gainer, having earlier been down as much as 1.5 pct, after posting Q4 revenue and core EPS ahead of analyst consensus
** Q4 core EPS of 18.1p vs Reuters consensus 17.9p, revenue of 6.286 bln stg vs Reuters consensus of 6.256 bln stg
** Growing demand for new drugs helped to offset slide in sales of its Advair medicine
** Shares (Berlin: DI6.BE - news) also see spike in volumes after news (venkateshasoumithri.mamidipudi.thomsonreuters.com@reuters.net)